Skip to main content

Advertisement

Log in

Time-of-flight secondary ion mass spectrometry (TOF-SIMS) imaging reveals cholesterol overload in the cerebral cortex of Alzheimer disease patients

  • Original Paper
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract

Although cholesterol has been involved in the pathophysiology of Alzheimer disease (AD), its distribution in the cerebral cortex over the course of AD is unknown. We describe an original method to quantify cholesterol distribution using time-of-flight secondary ion mass spectrometry imaging. Cholesterol was unevenly distributed along the cortical thickness, being more abundant close to the white matter, in both control and AD cases. However, the mean cholesterol signal was significantly higher in the lower half of the cortex in AD samples compared to controls. This increase, when converted into cortical layers, was statistically significant for layers III and IV and did not reach significance in layers V + VI, the variability being too high at the interface between grey and white matter. The density of neurofibrillary tangles and of senile plaques was not statistically linked to the abundance of cholesterol. Cholesterol overload thus appears a new and independent alteration of AD cerebral cortex. The structure in which cholesterol accumulates and the mechanism of this accumulation remain to be elucidated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Armstrong RA (2006) Laminar distribution of beta-amyloid deposits in dementia with Lewy bodies and in Alzheimer’s disease. Am J Alzheimers Dis Other Demen 21(3):175–181

    Article  PubMed  Google Scholar 

  2. Börner K, Nygren H, Hagenhoff B, Malmberg P, Tallarek E, Mansson JE (2006) Distribution of cholesterol and galactosylceramide in rat cerebellar white matter. Biochim Biophys Acta 1761(3):335–344

    Article  PubMed  Google Scholar 

  3. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82(4):239–259

    Article  PubMed  CAS  Google Scholar 

  4. Candy JM, Oakley AE, Mountfort SA, Taylor GA, Morris CM, Bishop HE, Edwardson JA (1992) The imaging and quantification of aluminium in the human brain using dynamic secondary ion mass spectrometry (SIMS). Biol Cell 74(1):109–118

    Article  PubMed  CAS  Google Scholar 

  5. Chochina SV, Avdulov NA, Igbavboa U, Cleary JP, O’Hare EO, Wood WG (2001) Amyloid beta-peptide1–40 increases neuronal membrane fluidity: role of cholesterol and brain region. J Lipid Res 42(8):1292–1297

    PubMed  CAS  Google Scholar 

  6. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261(5123):921–923

    Article  PubMed  CAS  Google Scholar 

  7. Cossec JC, Marquer C, Panchal M, Lazar AN, Duyckaerts C, Potier MC (2010) Cholesterol changes in Alzheimer’s disease: methods of analysis and impact on the formation of enlarged endosomes. Biochim Biophys Acta 1801(8):839–845

    Article  PubMed  CAS  Google Scholar 

  8. Cossec JC, Simon A, Marquer C, Moldrich RX, Leterrier C, Rossier J, Duyckaerts C, Lenkei Z, Potier MC (2010) Clathrin-dependent APP endocytosis and Abeta secretion are highly sensitive to the level of plasma membrane cholesterol. Biochim Biophys Acta 1801(8):846–852

    Article  PubMed  CAS  Google Scholar 

  9. Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, Troncoso JC, Mattson MP (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer’s disease. Proc Natl Acad Sci USA 101(7):2070–2075

    Article  PubMed  CAS  Google Scholar 

  10. Delaère P, Duyckaerts C, Brion JP, Poulain V, Hauw J-J (1989) Tau, paired helical filaments and amyloid in the neocortex: a morphometric study of 15 cases with graded intellectual status in aging and senile dementia of Alzheimer type. Acta Neuropathol (Berl) 77(6):645–653

    Article  Google Scholar 

  11. Distl R, Meske V, Ohm TG (2001) Tangle-bearing neurons contain more free cholesterol than adjacent tangle-free neurons. Acta Neuropathol 101(6):547–554

    PubMed  CAS  Google Scholar 

  12. Duyckaerts C, Delatour B, Potier MC (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118(1):5–36

    Article  PubMed  CAS  Google Scholar 

  13. Duyckaerts C, Hauw J-J, Bastenaire F, Piette F, Poulain C, Rainsard V, Javoy-Agid F, Berthaux P (1986) Laminar distribution of neocortical senile plaques in senile dementia of the Alzheimer type. Acta Neuropathol (Berl) 70(3–4):249–256

    Article  CAS  Google Scholar 

  14. Eckert GP, Hooff GP, Strandjord DM, Igbavboa U, Volmer DA, Muller WE, Wood WG (2009) Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients. Neurobiol Dis 35(2):251–257

    Article  PubMed  CAS  Google Scholar 

  15. Gottfries CG, Karlsson I, Svennerholm L (1996) Membrane components separate early-onset Alzheimer’s disease from senile dementia of the Alzheimer type. Int Psychogeriatr 8(3):365–372

    Article  PubMed  CAS  Google Scholar 

  16. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schurmann B, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Hull M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O’Donovan M, Owen MJ, Williams J (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet 41(10):1088–1093

    Article  PubMed  CAS  Google Scholar 

  17. Hof PR, Delacourte A, Bouras C (1992) Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases. Acta Neuropathol (Berl) 84(1):45–51

    Article  CAS  Google Scholar 

  18. Ikonen E, Parton RG (2000) Caveolins and cellular cholesterol balance. Traffic 1(3):212–217

    Article  PubMed  CAS  Google Scholar 

  19. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fievet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanche H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alperovitch A, Lathrop M, Amouyel P (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Genet 41(10):1094–1099

    Article  PubMed  CAS  Google Scholar 

  20. Lebouvier T, Perruchini C, Panchal M, Potier MC, Duyckaerts C (2009) Cholesterol in the senile plaque: often mentioned, never seen. Acta Neuropathol 117(1):31–34

    Article  PubMed  CAS  Google Scholar 

  21. Lewis DA, Campbell MJ, Terry RD, Morrison JH (1987) Laminar and regional distribution of neurofibrillary tangles and neuritic plaques in Alzheimer’s disease. A quantitative study of visual and auditory cortices. J Neurosci 7(6):1799–1808

    PubMed  CAS  Google Scholar 

  22. Majocha RE, Benes FM, Reifel JL, Rodenrys AM, Marotta CA (1988) Laminar-specific distribution and infrastructural detail of amyloid in the Alzheimer disease cortex visualized by computer-enhanced imaging of epitopes recognized by monoclonal antibodies. Proc Natl Acad Sci USA 85(16):6182–6186

    Article  PubMed  CAS  Google Scholar 

  23. Marquer C, Devauges V, Cossec JC, Liot G, Lecart S, Saudou F, Duyckaerts C, Leveque-Fort S, Potier MC (2011) Local cholesterol increase triggers amyloid precursor protein-Bace1 clustering in lipid rafts and rapid endocytosis. FASEB J 25(4):1295–1305

    Article  PubMed  CAS  Google Scholar 

  24. Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT (2012) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol 123(1):1–11

    Article  PubMed  CAS  Google Scholar 

  25. Nygren H, Malmberg P, Kriegeskotte C, Arlinghaus HF (2004) Bioimaging TOF-SIMS: localization of cholesterol in rat kidney sections. FEBS Lett 566(1–3):291–293

    Article  PubMed  CAS  Google Scholar 

  26. Ohm TG, Treiber-Held S, Distl R, Glockner F, Schonheit B, Tamanai M, Meske V (2003) Cholesterol and tau protein—findings in Alzheimer’s and Niemann Pick C’s disease. Pharmacopsychiatry 36(Suppl 2):S120–S126

    PubMed  CAS  Google Scholar 

  27. Panchal M, Loeper J, Cossec JC, Perruchini C, Lazar A, Pompon D, Duyckaerts C (2010) Enrichment of cholesterol in microdissected Alzheimer’s disease senile plaques as assessed by mass spectrometry. J Lipid Res 51(3):598–605

    Article  PubMed  CAS  Google Scholar 

  28. Pfrieger FW (2003) Role of cholesterol in synapse formation and function. Biochim Biophys Acta 1610(2):271–280

    Article  PubMed  CAS  Google Scholar 

  29. Puglielli L, Friedlich AL, Setchell KD, Nagano S, Opazo C, Cherny RA, Barnham KJ, Wade JD, Melov S, Kovacs DM, Bush AI (2005) Alzheimer disease beta-amyloid activity mimics cholesterol oxidase. J Clin Invest 115(9):2556–2563

    Article  PubMed  CAS  Google Scholar 

  30. Puglielli L, Tanzi RE, Kovacs DM (2003) Alzheimer’s disease: the cholesterol connection. Nat Neurosci 6(4):345–351

    Article  PubMed  CAS  Google Scholar 

  31. Quintana C, Wu TD, Delatour B, Dhenain M, Guerquin-Kern JL, Croisy A (2007) Morphological and chemical studies of pathological human and mice brain at the subcellular level: correlation between light, electron, and nanosims microscopies. Microsc Res Tech 70(4):281–295

    Article  PubMed  CAS  Google Scholar 

  32. Rogers J, Morrison JH (1985) Quantitative morphology and regional and laminar distribution of senile plaques in Alzheimer’s disease. J Neurosci 5(10):2801–2808

    PubMed  CAS  Google Scholar 

  33. Roher AE, Weiss N, Kokjohn TA, Kuo YM, Kalback W, Anthony J, Watson D, Luehrs DC, Sue L, Walker D, Emmerling M, Goux W, Beach T (2002) Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer’s disease. Biochemistry 41(37):11080–11090

    Article  PubMed  CAS  Google Scholar 

  34. Simons K, Ikonen E (1997) Functional rafts in cell membranes. Nature 387:569–572

    Article  PubMed  CAS  Google Scholar 

  35. Sjövall P, Lausmaa J, Johansson B (2004) Mass spectrometric imaging of lipids in brain tissue. Anal Chem 76(15):4271–4278

    Article  PubMed  Google Scholar 

  36. Solé-Domènech S, Sjövall P, Vukojevic V, Codita A, Salve S, Schalling V, LaFerla F, Giménez-Llort L, Nilsson P, Hammarström P, Terenius L, Johansson B (2011) Cholesterol accumulates in the vicinity of amyloid-beta deposits in brain tissue. Paper presented at the Alzheimer’s Association International Conference, Paris

  37. Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58(12):1791–1800

    Article  PubMed  Google Scholar 

  38. Touboul D, Brunelle A, Laprévote O (2006) Structural analysis of secondary ions by post-source decay in time-of-flight secondary ion mass spectrometry. Rapid Commun Mass Spectrom 20(4):703–709

    Article  PubMed  CAS  Google Scholar 

  39. Touboul D, Halgand F, Brunelle A, Kersting R, Tallarek E, Hagenhoff B, Laprévote O (2004) Tissue molecular ion imaging by gold cluster ion bombardment. Anal Chem 76(6):1550–1559

    Article  PubMed  CAS  Google Scholar 

  40. Touboul D, Kollmer F, Niehuis E, Brunelle A, Laprévote O (2005) Improvement of biological time-of-flight-secondary ion mass spectrometry imaging with a bismuth cluster ion source. J Am Soc Mass Spectrom 16(10):1608–1618

    Article  PubMed  CAS  Google Scholar 

  41. Touboul D, Laprévote O, Brunelle A (2011) Micrometric molecular histology of lipids by mass spectrometry imaging. Curr Opin Chem Biol 15(5):725–732

    Article  PubMed  CAS  Google Scholar 

  42. Weibel ER (1979) Stereological methods. In: Practical methods for biological morphometry, vol 1. Academic Press, London

  43. Xiong H, Callaghan D, Jones A, Walker DG, Lue LF, Beach TG, Sue LI, Woulfe J, Xu H, Stanimirovic DB, Zhang W (2008) Cholesterol retention in Alzheimer’s brain is responsible for high beta- and gamma-secretase activities and Abeta production. Neurobiol Dis 29(3):422–437

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Dr Véronique Sazdovitch for her help in collecting and analyzing the samples. The help of the technical staff of Escourolle Neuropathology Laboratory is greatly acknowledged. This work was supported by the Agence Nationale de la Recherche (grants ANR-07-NEURO-009-ChoAD, ANR-2010-BLAN-0805-01 and -02 MASS-IMAGE, and ANR-2010-MALZ-10303 CholAD) and a grant from “Projet Hospitalier de Recherche Clinique” (PHRC), project IMAD. The work was partly funded by France-Alzheimer Association (Project: Identification des partenaires moléculaires du peptide Abeta). The human samples were obtained through the Brain Bank GIE NeuroCEB funded by a consortium of Patients’ Associations (France Alzheimer, France Parkinson, CSC, ARSEP Fondation).

Conflict of interest

The authors disclose no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Charles Duyckaerts.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lazar, A.N., Bich, C., Panchal, M. et al. Time-of-flight secondary ion mass spectrometry (TOF-SIMS) imaging reveals cholesterol overload in the cerebral cortex of Alzheimer disease patients. Acta Neuropathol 125, 133–144 (2013). https://doi.org/10.1007/s00401-012-1041-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-012-1041-1

Keywords

Navigation